Background: Although anthracycline (AC) exposure predisposes one to cardiotoxicity, early subclinical markers are largely unavailable. In a recent animal model, we identified a cardiovascular magnetic resonance (CMR) method for measuring gadolinium signal intensity (Gd-SI) changes that identified early histopathologic evidence of myocellular injury after AC therapy that subsequently forecasted a decrement in left ventricular ejection fraction. The purpose of this study was to determine in patients if Gd-SI changed after AC versus non-AC therapy.
